| February 2, 2018
The compound, BCI-838, is already in human clinical trials as a possible treatment for depression.
The test uses levels of plasma amyloid-β to estimate the buildup of protein plaques in the brain.
Researchers are using souped-up mass spectrometry to localize proteins within brain cells.
New technology could open doors for researchers studying animals’ most complex organ.
After years of obscurity, strains of mice with mutations in particular genes are thrust to the fore of autism research.
In chapter 1, “The Bad Language Brain: Neuroscience and Swearing,” author Emma Byrne sets the scene for her book by telling the story of the hapless and potty-mouthed Phineas Gage.
Researchers map learning-induced chromatin alterations in mouse brain cells, and find that many affect autism-associated genes.
In mice and flies, the Arc protein forms capsids and carries genetic information.
Researchers identify patterns of neural activity ranging from a few days to four weeks in individuals with epilepsy.
Three studies—one of mice and two of human genetics—describe the role of two proteins, adenylyl cyclase and melanocortin 4 receptor, in the development of obesity and diabetes.
The nationwide experiment will initially include around 100,000 volunteers.
After implantation, the tissue developed blood vessels and became integrated into neuronal networks in the animals’ brains.
A preliminary clinical trial finds that the personalized therapy improves survival rates and has no severe side-effects.
Many cities around the globe, including Washington, DC, saw shrunken crowd sizes, and numerous events turned into rallies rather than processions.
© 1986-2018 The Scientist
